Lipoedema Localized adiposity
Conditions
Interventions
This is a randomized, controlled, two-arm, double-blind clinical study. Experimental group: 12 individuals with bilateral lipedema in the lower limbs in stage I or II (application of shock wave therap
Sponsors
Universidade Federal do Espírito Santo
Universidade Federal do Espírito Santo
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult women aged 18 years or older; Diagnosis of bilateral lipedema in the lower limbs in stage I or II, following the guidelines and consensus; Presence of pain and/or fatigue in the lower limbs in the last week: visual analogue scale from 0 to 10 and fatigue severity scale, with a value equal to or above 4
Exclusion criteria
Exclusion criteria: Women with a body mass index greater than 50; with heart failure; use of a pacemaker or cardioverter, presence of acute venous disease; severe peripheral arterial disease; with active skin infection/inflammatory disease; Pregnant women or women who are breastfeeding; women diagnosed with cancer, with a history of deep vein disease and/or thrombosis and Women who have allergic reactions to the use of elastic bandages (Kinesio taping)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility and acceptability of the intervention protocol will be assessed through recruitment, adherence, retention and randomization rates of eligible participants evaluated throughout the study period | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in lower limb fatigue is expected, assessed using the Fatigue Severity Scale before and after completion of the intervention protocol;A reduction in lower limb volume is expected, indirectly assessed through serial perimetry using the truncated cone method before and after completion of the intervention protocol;A reduction in lower limb pain intensity is expected, assessed using the Visual Analog Scale before and after completion of the intervention protocol;An improvement in pressure pain threshold is expected, assessed through algometry before and after completion of the intervention protocol;An improvement in lipedema-related symptoms is expected, assessed using the Questionnaire for Symptoms and Impact of Lipedema before and after completion of the intervention protocol;An improvement in lower limb function is expected, assessed using the Lower Extremity Functional Scale before and after completion of the intervention protocol;A reduction in lower limb volume is expected, indirectly assessed through serial perimetry using the truncated cone method before and after completion of the intervention protocol;A reduction in lower limb pain intensity is expected, assessed using the Visual Analog Scale before and after completion of the intervention protocol;An improvement in pressure pain threshold is expected, assessed through algometry before and after completion of the intervention protocol;An improvement in lipedema-related symptoms is expected, assessed using the Questionnaire for Symptoms and Impact of Lipedema before and after completion of the intervention protocol;An improvement in lower limb function is expected, assessed using the Lower Extremity Functional Scale before and after completion of the intervention protocol;A reduction in lower limb volume is expected, indirectly assessed through serial perimetry using the truncated cone method before and after completion of the intervention protocol;A reduction in lower limb pain intensity is exp | — |
Countries
BR
Contacts
Public ContactCintia Santuzzi
Universidade Federal do Espírito Santo
Outcome results
None listed